national stem-cell therapy logo

Stem cells helping patients with Parkinson’s Disease

Help Spread The Word, Share Post:

News segment from Houston’s KPRC talking about the first FDA approved stem cell trial that is happening to help patient’s dealing with Parkinson’s Disease.

Video Transcript:

More than 10 million people worldwide are living with Parkinson’s and 60,000 are in the U.S..

It’s a chronic progressive disease, which means it gets worse over time. But a new therapy currently in trials is proving to be a game changer. TV health reporter Haley Hernandez has more on the first FDA approved stem cell trial that’s actually happening right here in Houston. And that’s a really important thing to make it known because there are a lot of claims that are made that stem cells can cure and the truth is it has not been well studied until now.

This is the first FDA approved trial and it is happening at UT Health.

It’s a blinded study, so participants do not know if they’re getting the real treatment or a placebo. But for Marty Young, in The Woodlands, he’s pretty sure he knows which category he’s in.

Marty Young has led a busy life working, enjoying family, and flying; all things he loved to stay busy with, all while Parkinson’s progressed.

Recently, things like snapping are a big accomplishment. This movement had been lost with the disease, but Marty has regained a tremendous amount of movement and stability.

In the trial led by Doctor Maya Parkinson’s patients are injected with stem cells and followed for a year.

So far, she says they’re seeing incredible improvements.

Huge differences in the responses and in the rating scales. Stem cells have just tremendous potential, and there’s no reason not to truly believe that ultimately when we get them in the right form from the right tissue, etc, that we’re going to have a very powerful treatment.

Marty believes this has relieved him of many symptoms, including a bonus of curing his knee pain.

And now a phase 2 trial is in the works and they started recruiting for that in March. The idea is that if phase 2 and then a possible face 3 are a success, we should learn a lot about how the stem cells interact with Parkinson’s and then the proper dosing of the stem cells. And that could come, ultimately, in the next three to five years.

*** All content on NationalStemCellTherapy.com is for informational purposes only. All medical questions and concerns should always be consulted with your licensed healthcare provider.

*** All content on NationalStemCellTherapy.com is for informational purposes only. All medical questions and concerns should always be consulted with your licensed healthcare provider.

Stay Connected

More Updates